INFUSYSTEM HOLDINGS INC

INFUSYSTEM HOLDINGS INC (INFU)

$8.8

-0.1

(-1.12%)

Live

Insights on INFUSYSTEM HOLDINGS INC

  • Increasing Revenue

    Revenue is up for the last 6 quarters, 26.51M → 30.37M (in $), with an average increase of 2.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 443.0K → -324.0K (in $), with an average decrease of 239.3% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical Inc has given 33.9% return, outperforming this stock by 41.3%

  • Vs WST

    In the last 3 years, West Pharmaceutical Services, Inc. has given 58.7% return, outperforming this stock by 82.0%

Performance

  • $8.80
    $9.17
    $8.80
    downward going graph

    0.0%

    Downside

    Day's Volatility :4.03%

    Upside

    4.03%

    downward going graph
  • $6.10
    $10.88
    $8.80
    downward going graph

    30.68%

    Downside

    52 Weeks Volatility :43.93%

    Upside

    19.12%

    downward going graph

Returns

PeriodINFUSYSTEM HOLDINGS INCSector (Health Care)Index (Russel 2000)
3 Months
-5.22%
0.3%
-6.7%
6 Months
3.73%
-8.3%
-6.2%
1 Year
-7.96%
-4.8%
-6.3%
3 Years
-23.93%
23.8%
26.9%

Highlights

Market Capitalization
186.3M
Book Value
$2.31
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.0
PE Ratio
0.0
PEG Ratio
0.0
Wall Street Target Price
15.17
Profit Margin
0.06%
Operating Margin TTM
1.83%
Return On Assets TTM
1.29%
Return On Equity TTM
0.13%
Revenue TTM
113.4M
Revenue Per Share TTM
5.47
Quarterly Revenue Growth YOY
13.3%
Gross Profit TTM
62.5M
EBITDA
15.1M
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
-0.5
EPS Estimate Current Year
0.06
EPS Estimate Next Year
0.22
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
0.03

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for INFUSYSTEM HOLDINGS INC(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 72.39%

Current $8.80
Target $15.17

Company Financials

FY17Y/Y Change
Revenue
71.1M
↑ 0.82%
Net Income
-20.7M
↑ 9227.48%
Net Profit Margin
-29.13%
↓ 28.82%
FY18Y/Y Change
Revenue
67.1M
↓ 5.54%
Net Income
-1.1M
↓ 94.71%
Net Profit Margin
-1.63%
↑ 27.5%
FY19Y/Y Change
Revenue
81.1M
↑ 20.82%
Net Income
1.4M
↓ 224.29%
Net Profit Margin
1.68%
↑ 3.31%
FY20Y/Y Change
Revenue
97.4M
↑ 20.06%
Net Income
17.3M
↑ 1173.48%
Net Profit Margin
17.8%
↑ 16.12%
FY21Y/Y Change
Revenue
102.4M
↑ 5.13%
Net Income
1.4M
↓ 91.81%
Net Profit Margin
1.39%
↓ 16.41%
FY22Y/Y Change
Revenue
109.9M
↑ 7.36%
Net Income
18.0K
↓ 98.73%
Net Profit Margin
0.02%
↓ 1.37%
Q4 FY21Q/Q Change
Revenue
26.5M
↓ 0.18%
Net Income
387.0K
↓ 186.38%
Net Profit Margin
1.46%
↑ 3.15%
Q1 FY22Q/Q Change
Revenue
26.8M
↑ 0.92%
Net Income
-368.0K
↓ 195.09%
Net Profit Margin
-1.38%
↓ 2.84%
Q2 FY22Q/Q Change
Revenue
27.0M
↑ 1.04%
Net Income
-164.0K
↓ 55.43%
Net Profit Margin
-0.61%
↑ 0.77%
Q3 FY22Q/Q Change
Revenue
27.3M
↑ 0.88%
Net Income
443.0K
↓ 370.12%
Net Profit Margin
1.62%
↑ 2.23%
Q4 FY22Q/Q Change
Revenue
28.8M
↑ 5.69%
Net Income
107.0K
↓ 75.85%
Net Profit Margin
0.37%
↓ 1.25%
Q1 FY23Q/Q Change
Revenue
30.4M
↑ 5.34%
Net Income
-324.0K
↓ 402.8%
Net Profit Margin
-1.07%
↓ 1.44%
FY17Y/Y Change
Total Assets
68.9M
↓ 28.51%
Total Liabilities
37.9M
↓ 16.92%
FY18Y/Y Change
Total Assets
64.1M
↓ 6.98%
Total Liabilities
43.6M
↑ 15.04%
FY19Y/Y Change
Total Assets
79.2M
↑ 23.65%
Total Liabilities
56.9M
↑ 30.39%
FY20Y/Y Change
Total Assets
45.2M
↓ 42.89%
Total Liabilities
56.2M
↓ 1.14%
FY21Y/Y Change
Total Assets
97.6M
↑ 115.69%
Total Liabilities
49.3M
↓ 12.31%
FY22Y/Y Change
Total Assets
99.4M
↑ 1.85%
Total Liabilities
51.4M
↑ 4.2%
Q4 FY21Q/Q Change
Total Assets
97.6M
↑ 2.95%
Total Liabilities
49.3M
↑ 2.03%
Q1 FY22Q/Q Change
Total Assets
98.2M
↑ 0.67%
Total Liabilities
52.2M
↑ 5.82%
Q2 FY22Q/Q Change
Total Assets
98.8M
↑ 0.59%
Total Liabilities
52.3M
↑ 0.26%
Q3 FY22Q/Q Change
Total Assets
99.0M
↑ 0.17%
Total Liabilities
51.2M
↓ 2.19%
Q4 FY22Q/Q Change
Total Assets
99.4M
↑ 0.41%
Total Liabilities
51.4M
↑ 0.41%
Q1 FY23Q/Q Change
Total Assets
102.3M
↑ 2.89%
Total Liabilities
54.0M
↑ 5.09%
FY17Y/Y Change
Operating Cash Flow
7.6M
↓ 4.12%
Investing Cash Flow
1.1M
↓ 119.7%
Financing Cash Flow
-8.6M
↓ 57200.0%
FY18Y/Y Change
Operating Cash Flow
11.4M
↑ 50.22%
Investing Cash Flow
-5.0M
↓ 573.31%
Financing Cash Flow
-5.6M
↓ 35.11%
FY19Y/Y Change
Operating Cash Flow
13.9M
↑ 21.81%
Investing Cash Flow
-19.6M
↑ 294.12%
Financing Cash Flow
4.1M
↓ 173.71%
FY20Y/Y Change
Operating Cash Flow
20.3M
↑ 46.16%
Investing Cash Flow
-12.2M
↓ 38.08%
Financing Cash Flow
-1.1M
↓ 127.26%
FY21Y/Y Change
Operating Cash Flow
18.3M
↓ 9.68%
Investing Cash Flow
-21.3M
↑ 75.26%
Financing Cash Flow
-6.5M
↑ 478.6%
Q4 FY21Q/Q Change
Operating Cash Flow
3.7M
↓ 35.92%
Investing Cash Flow
-5.6M
↑ 27.19%
Financing Cash Flow
1.9M
↓ 241.8%
Q1 FY22Q/Q Change
Operating Cash Flow
4.1M
↑ 9.89%
Investing Cash Flow
-2.1M
↓ 61.92%
Financing Cash Flow
-1.7M
↓ 188.59%
Q2 FY22Q/Q Change
Operating Cash Flow
5.4M
↑ 32.83%
Investing Cash Flow
-2.8M
↑ 29.77%
Financing Cash Flow
-2.7M
↑ 59.09%
Q3 FY22Q/Q Change
Operating Cash Flow
3.5M
↓ 36.2%
Investing Cash Flow
-3.5M
↑ 25.93%
Financing Cash Flow
98.0K
↓ 103.59%

Technicals Summary

Sell

Neutral

Buy

INFUSYSTEM HOLDINGS INC is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
0.79%
3.73%
-7.96%
-23.93%
182.54%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
1.28%
13.5%
34.82%
60.24%
100.3%
ResMed Inc.
ResMed Inc.
-8.1%
-6.41%
5.89%
33.71%
110.04%
Becton, Dickinson and Company
Becton, Dickinson and Company
-9.12%
-3.3%
-5.74%
-1.52%
7.87%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-6.18%
46.38%
10.67%
61.92%
264.96%
Alcon AG
Alcon AG
9.79%
14.75%
5.78%
24.18%
36.2%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
0.0
0.0
0.0
0.06
0.0
0.01
0.0
2.31
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
83.4
83.4
3.27
5.47
0.11
0.07
0.0
32.01
ResMed Inc.
ResMed Inc.
36.76
36.76
1.74
6.52
0.24
0.12
0.01
26.77
Becton, Dickinson and Company
Becton, Dickinson and Company
44.32
44.32
2.31
12.2
0.07
0.03
0.02
90.44
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
47.18
47.18
4.06
7.69
0.22
0.13
0.0
37.42
Alcon AG
Alcon AG
114.57
114.57
NA
2.64
0.02
0.02
0.0
40.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
Buy
$186.3M
182.54%
0.0
0.06%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$107.5B
100.3%
83.4
20.4%
ResMed Inc.
ResMed Inc.
Buy
$31.7B
110.04%
36.76
21.49%
Becton, Dickinson and Company
Becton, Dickinson and Company
Buy
$68.5B
7.87%
44.32
8.6%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$25.5B
264.96%
47.18
19.15%
Alcon AG
Alcon AG
Buy
$38.9B
36.2%
114.57
3.84%

Company Information

InfuSystem Holdings, Inc., is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services ('ITS'), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, and Wound Therapy businesses. The second platform, Durable Medical Equipment Services ('DME Services'), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payor clients. The DME Services segment is comprised of direct payor rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada.

Organization
INFUSYSTEM HOLDINGS INC
Employees
420
CEO
Mr. Richard A. DiIorio
Industry
Health Technology

FAQs